These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Immunotolerance and its production]. Hraba T; Göing H Arzneimittelforschung; 1969 Aug; 19(8):1161-9. PubMed ID: 4185643 [No Abstract] [Full Text] [Related]
3. [On the effects of immunosuppressive and cytostatic substances on the oxidative metabolism of leukocytes during the rejection of kidney homotransplants]. Păuşescu E; Dincă A; Chirvasie R Z Gesamte Inn Med; 1968 Jan; 23(2):33-7. PubMed ID: 4879774 [No Abstract] [Full Text] [Related]
4. [Study of new immunodepressants among antineoplastic agents]. Drake RB; Grigalinovich GA; Kalnberz VK; Lidak MIu Vestn Akad Med Nauk SSSR; 1971; 26(1):31-3. PubMed ID: 4928209 [No Abstract] [Full Text] [Related]
5. Screening of immunosuppressive drugs in the allotransplantation reaction between mice differing at the H-3 locus. Nouza K Folia Biol (Praha); 1966; 12(4):266-77. PubMed ID: 5330212 [No Abstract] [Full Text] [Related]
10. [Immunosuppression and induction of tolerance by 3-(2-chloroethyl)-2(2-mesyloxyethylamino)-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide (ASTA 5122)]. Botzenhardt U; Lemmel EM Arzneimittelforschung; 1974 Aug; 24(8):1167-72. PubMed ID: 4154071 [No Abstract] [Full Text] [Related]
11. [Effect of rubomycin in combination with some cytostatic preparations on formation of hemagglutinins in mice]. Shapovalova SP Antibiotiki; 1969 Dec; 14(12):1101-4. PubMed ID: 4984363 [No Abstract] [Full Text] [Related]
13. Enhancement of immune response by 1.6-dibromo-1. Börzsönyi M; Connors TA; Lapis K Neoplasma; 1969; 16(4):393-6. PubMed ID: 5344225 [No Abstract] [Full Text] [Related]
14. [Effect of immunosuppressive drugs on the transplantation immunology. I. Effect on the blastic reaction in the regional lymph nodes]. Patkowski J Postepy Hig Med Dosw; 1968; 22(6):911-56. PubMed ID: 4885890 [No Abstract] [Full Text] [Related]
15. [Correlation between lymphocytes and polyblast-macrophages and their cytologic characteristic during the use of antineoplastic agents]. Korol'chuk VP; Iushkov SF Farmakol Toksikol; 1971; 34(2):213-9. PubMed ID: 5563396 [No Abstract] [Full Text] [Related]
16. [Immunosuppressive drugs in organ transplantations]. Di Mezza F Minerva Chir; 1968 Mar; 23(5):212-29. PubMed ID: 4174995 [No Abstract] [Full Text] [Related]
17. [The immunosuppressive agents. VI. Immunosuppressive action of anti-lymphocyte serums]. Renoux M; Mikol C Presse Med (1893); 1967 Oct; 75(43):2167-70. PubMed ID: 6053126 [No Abstract] [Full Text] [Related]
18. [Lymphocyte capacity to form rosettes E as indicator of the degree of reduced immunological reactivity in immunosuppressive and cytostatic therapy (author's transl)]. Korcáková L; Kaslík J Cas Lek Cesk; 1978 Jan; 117(2):50-2. PubMed ID: 343915 [No Abstract] [Full Text] [Related]
19. Immunosuppressive action of L-asparaginase in mice. Nelson SD; Lee MB; Bridges JM Br J Haematol; 1969 Dec; 17(6):610. PubMed ID: 4901993 [No Abstract] [Full Text] [Related]
20. [Effect of tavromycetin of the formation of antibodies in laboratory animals]. Shapovalova SP Antibiotiki; 1968 Jan; 13(1):17-21. PubMed ID: 4873974 [No Abstract] [Full Text] [Related] [Next] [New Search]